Modulation of Glucagon-like Peptide 1 and Energy Metabolism by Inulin and Oligofructose: Experimental Data
Open Access
- 1 November 2007
- journal article
- review article
- Published by Elsevier BV in Journal of Nutrition
- Vol. 137 (11), 2547S-2551S
- https://doi.org/10.1093/jn/137.11.2547s
Abstract
Inulin-type fructans have been tested for their capacity to modulate lipid and glucose metabolism in several animal models. Oligofructose (OFS) decreases food intake, fat mass development, and hepatic steatosis in normal and in obese rats; moreover, it exerts an antidiabetic effect in streptozotocin-treated rats and high-fat-fed mice. In most cases, the beneficial effects of OFS are linked to an increase of glucagon-like peptide-1 (GLP-1) level in the portal vein and of GLP-1 and proglucagon mRNA, its precursor, in the proximal colon. In this organ, OFS increases the number of GLP-1-positive L cells by promoting factors (Neurogenin 3 and NeuroD) involved in the differentiation of stem cells into L cells. The chronic administration of GLP-1 receptor antagonist exendin 9–39 totally prevents the beneficial effects of OFS (improved glucose tolerance, fasting blood glucose, glucose-stimulated insulin secretion, insulin-sensitive hepatic glucose production, and reduced body weight gain). Furthermore GLP-1 receptor knockout mice are completely insensitive to the antidiabetic actions of OFS. These findings highlight the potential interest of enhancing endogenous GLP-1 secretion by inulin-type fructans for the prevention/treatment of obesity and type 2 diabetes. Moreover, OFS is also able to modulate other gastrointestinal peptides (such as PYY and ghrelin) that could be involved in the control of food intake. Several studies in humans already support interest in OFS in the control of satiety, triglyceridemia, or steatohepatitis. The link with gut peptides production in humans remains to be proven.Keywords
This publication has 34 references indexed in Scilit:
- Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of ratsBritish Journal of Nutrition, 2007
- Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant miceProceedings of the National Academy of Sciences of the United States of America, 2006
- Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed miceLife Sciences, 2006
- Oligofructose promotes satiety in healthy human: a pilot studyEuropean Journal of Clinical Nutrition, 2005
- Carbohydrate bioavailabilityBritish Journal of Nutrition, 2005
- Involvement of endogenous glucagon-like peptide-1(7–36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated ratsJournal of Endocrinology, 2005
- Harnessing the gut to treat diabetesPediatric Diabetes, 2004
- Clarifying concepts about macronutrients’ effects on satiation and satietyJournal of the American Dietetic Association, 2004
- Effect of fat replacement by inulin or lupin-kernel fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in menBritish Journal of Nutrition, 2004
- Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospectsBritish Journal of Nutrition, 2002